Compounds

Details Compounds Compounds

2004-02-13

2009-06-23

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S122000

Reexamination Certificate

active

07550480

ABSTRACT:
Novel substituted 1,5,7-trisubstituted-1,8-napthyridin-2(1H)-one compounds; 1,5,7 trisubstituted-1,6-napthyridine-2-(1H)-one compounds and 1,5,7-trisubstituted quinoline-2(1H)-one compounds, processes for the preparation thereof, the use thereof in treating CSBP/p38 kinase mediated diseases and pharmaceutical compositions for use in such therapy.

REFERENCES:
patent: 3843663 (1974-10-01), Williams et al.
patent: 3962262 (1976-06-01), Williams et al.
patent: 4031103 (1977-06-01), Williams et al.
patent: 4560691 (1985-12-01), Lesher et al.
patent: 4897395 (1990-01-01), Duch et al.
patent: 5409930 (1995-04-01), Spada et al.
patent: 5426110 (1995-06-01), Gossett et al.
patent: 5547954 (1996-08-01), Henrie, II et al.
patent: 5597776 (1997-01-01), Bratz et al.
patent: 5620981 (1997-04-01), Blankley et al.
patent: 5733914 (1998-03-01), Blankley et al.
patent: 5817670 (1998-10-01), Takayama et al.
patent: 5945422 (1999-08-01), Doherty et al.
patent: 5989588 (1999-11-01), Korn et al.
patent: 6200977 (2001-03-01), Cushing et al.
patent: 6498163 (2002-12-01), Boschelli et al.
patent: 6528513 (2003-03-01), Cushing et al.
patent: 6809199 (2004-10-01), Doherty et al.
patent: 6875769 (2005-04-01), Chen
patent: 2003/0092712 (2003-05-01), Doherty et al.
patent: 2003/0114671 (2003-06-01), Chen
patent: 0 168 037 (1986-01-01), None
patent: 0 278 686 (1988-05-01), None
patent: 1-261306 (1989-10-01), None
patent: 2003/127542 (2003-05-01), None
patent: WO 02/058695 (2002-08-01), None
Ferrarini et al., Farmaco (1998), 53(12), 741-746.
Carboni et al., Gazzetta Chimica Italiana (1967), 97(8), 1262-73.
Ferrarini et al., Journal of heterocyclic chemistry, 1984, 21(2), 417-19.
Ferrarini et al., Annali di Chimica, 1971, 61(5), 318-25.
Carboni et al., Gazzetta Chimica Italiana (1968), 98(10), 1174-88.
Anderson et al., J. Org. Chem., vol. 42(6) pp. 993-996 (1977).
Baker et al., J. Heterocyclic Chem., 1964, vol. 1, pp. 263-270.
Carboni et al.,Gazzetta Chimica Italiana, vol. 97(8) pp. 1262-1273 (1967).
Carboni et al.,Gazzetta Chimica Italiana, vol. 98(10) pp. 1174-1188 (1968).
Ferrarini et al.,Journal of Heterocyclic Chemistry, vol. 21(2) pp. 417-419 (1984).
Ferrarini et al.,Journal of Heterocyclic Chemistry, vol. 34(5) pp. 1501-1510 (1997).
Hurlbert, et al., J. Med. Chem., 1968, vol. 11, pp. 703-707.
Rewcastle et al., Journal of Medicinal Chemistry, 1996 39(6), pp. 1823-1835.
Schoffstall et al., J. Org. Chem., 1971, 36(16), pp. 2385-2387.
Victory et al., J. Heterocycl. Chem, 1988, vol. 25, pp. 245-247.
Belled, et al.,Anales De Quimica, vol. 86 (4) pp. 431-435 (1990).
Ferrarini et al.,Societa Chimica Italiana, vol. 44 (6) pp. 579-584 (1989).
Ferrarini et al.,Societa Chimica Italiana, vol. 53 (12) pp. 741-746 (1998).
Savarin, et al.,Organic Letters, vol. 4 (12) pp. 2071-2074 (2002).
Singh, et al.,Am. Chem. Soc., vol. 35 (26) pp. 4858-4865 (1992).
Wenji Yin, et al.,Drug Metabolism and Disposition, vol. 31 (2) pp. 215-223 (2003).

Affiliated with

Also associated with

Rating

Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4116677